Adler B, Bulach D, Chung J, Doughty S, Hunt M, Rajakumar K, Serrano M, van Zanden A, Zhang Y, Ruffolo C
Department of Microbiology, Monash University, Melbourne, Australia.
J Biotechnol. 1999 Aug 20;73(2-3):83-90. doi: 10.1016/s0168-1656(99)00111-x.
Pasteurella multocida is the causative agent of fowl cholera and other diseases of production animals. Isolates are classified into five groups based on capsular antigens and into 16 serotypes based on LPS antigens. Strains causing fowl cholera are most frequently designated A:1, A:3 or A:4. Whole cell bacterins can provide some degree of protection, but only against the homologous LPS serotype. There is good evidence that cross-protective antigens are expressed only under in vivo conditions. Empirically derived, live, attenuated vaccines can protect against heterologous serotypes, but because the basis for attenuation is undefined, reversion to virulence is not uncommon. Work in our laboratory is aimed at using a variety of approaches to identify potential protective antigens or virulence genes to be used as candidates for attenuating mutations or as the basis for vaccine antigen delivery systems. The gene encoding an outer membrane protein, Oma87, which is a homologue of the D15 protective antigen of Haemophilus influenzae, was cloned and sequenced. Rabbit antiserum prepared against recombinant Oma87 could passively protect mice against infection. Type 4 fimbriae form the basis of vaccines against ovine footrot and bovine keratoconjunctivitis. We have identified type 4 fimbriae on the surface of P. multocida, purified the fimbrial subunit protein, PtfA, and determined its N-terminal amino acid sequence. Subsequent cloning of the ptfA gene and its inactivation will now be used to assess the importance of type 4 fimbriae in virulence. There has long been anecdotal evidence for the importance of capsule in virulence, but unequivocal genetic evidence for such a role is lacking. We have cloned and characterised the capsule biosynthetic locus in P. multocida A:1 and identified four bex genes involved in capsule transport and genes encoding enzymes involved in the biosynthesis and transfer of the N-acetyl glucosamine and glucuronic acid components of the capsule. It has been suggested that the low concentration of available iron in vivo acts as an environmental cue for expression of cross-protective antigens. Accordingly, we have cloned and characterised the gene encoding transferrin binding protein, Tbpl, so that its role in immunity and virulence can be investigated. Although P. multocida is not normally considered haemolytic, we have observed haemolysis under anaerobic conditions. Standard library construction and screening resulted in the identification of the mesA gene which encodes an esterase enzyme resulting in a haemolytic phenotype under anaerobic conditions. Virulence studies with mesA- mutants were performed to assess its role in pathogenesis. Using a promoterless phoA gene vector system, the cloning of proteins homologous to known surface proteins of other species as well as proteins unique to P. multocida, allowing their potential as vaccine components to be assessed.
多杀性巴氏杆菌是禽霍乱及其他生产动物疾病的病原体。分离株根据荚膜抗原分为五组,根据脂多糖抗原分为16个血清型。引起禽霍乱的菌株最常见的是A:1、A:3或A:4。全细胞菌苗可提供一定程度的保护,但仅针对同源脂多糖血清型。有充分证据表明交叉保护抗原仅在体内条件下表达。凭经验获得的减毒活疫苗可预防异源血清型,但由于减毒的基础不明确,毒力回复并不罕见。我们实验室的工作旨在采用多种方法鉴定潜在的保护性抗原或毒力基因,用作减毒突变的候选基因或疫苗抗原递送系统的基础。编码外膜蛋白Oma87的基因被克隆和测序,该蛋白是流感嗜血杆菌D15保护性抗原的同源物。针对重组Oma87制备的兔抗血清可被动保护小鼠免受感染。4型菌毛是抗羊腐蹄病和牛角膜结膜炎疫苗的基础。我们已在多杀性巴氏杆菌表面鉴定出4型菌毛,纯化了菌毛亚基蛋白PtfA,并确定了其N端氨基酸序列。随后对ptfA基因的克隆及其失活将用于评估4型菌毛在毒力中的重要性。长期以来一直有关于荚膜在毒力中重要性的传闻证据,但缺乏这种作用的确切遗传学证据。我们已克隆并鉴定了多杀性巴氏杆菌A:1中的荚膜生物合成位点,确定了四个参与荚膜转运的bex基因以及编码参与荚膜N-乙酰葡糖胺和葡糖醛酸成分生物合成和转移的酶的基因。有人提出,体内可利用铁的低浓度作为交叉保护抗原表达的环境信号。因此,我们已克隆并鉴定了编码运铁蛋白结合蛋白Tbpl的基因,以便研究其在免疫和毒力中的作用。尽管多杀性巴氏杆菌通常不被认为具有溶血活性,但我们在厌氧条件下观察到了溶血现象。通过标准文库构建和筛选鉴定出了mesA基因,该基因编码一种酯酶,在厌氧条件下导致溶血表型。对mesA突变体进行了毒力研究以评估其在发病机制中的作用。使用无启动子phoA基因载体系统,克隆了与其他物种已知表面蛋白同源的蛋白以及多杀性巴氏杆菌特有的蛋白,从而可以评估它们作为疫苗成分的潜力。